These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 25196314

  • 1. Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy.
    Casey DE, Laubmeier KK, Eudicone JM, Marcus R, Berman RM, Rahman Z, Sheehan J.
    Int J Clin Pract; 2014 Nov; 68(11):1301-8. PubMed ID: 25196314
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
    Nelson JC, Thase ME, Bellocchio EE, Rollin LM, Eudicone JM, McQuade RD, Marcus RN, Berman RM, Baker RA.
    Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058
    [Abstract] [Full Text] [Related]

  • 3. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM.
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [Abstract] [Full Text] [Related]

  • 4. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
    Wisniewski SR, Chen CC, Kim E, Kan HJ, Guo Z, Carlson BX, Tran QV, Pikalov A.
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM.
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [Abstract] [Full Text] [Related]

  • 6. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN.
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [Abstract] [Full Text] [Related]

  • 7. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
    Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, Khan A.
    J Clin Psychiatry; 2007 Jun; 68(6):843-53. PubMed ID: 17592907
    [Abstract] [Full Text] [Related]

  • 8. Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysis.
    Stewart TD, Hatch A, Largay K, Sheehan JJ, Marler SV, Berman RM, Nelson JC.
    J Affect Disord; 2014 Jun; 162():20-5. PubMed ID: 24766999
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH, Lin SH, Jang FL.
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.
    Steffens DC, Nelson JC, Eudicone JM, Andersson C, Yang H, Tran QV, Forbes RA, Carlson BX, Berman RM.
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):564-72. PubMed ID: 20827794
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy.
    Nelson JC, Rahman Z, Laubmeier KK, Eudicone JM, McQuade RD, Berman RM, Marcus RN, Baker RA, Sheehan JJ.
    CNS Spectr; 2014 Dec; 19(6):528-34. PubMed ID: 24642260
    [Abstract] [Full Text] [Related]

  • 12. Adjunctive aripiprazole for depression: predictive value of early assessment.
    Muzina DJ, Chambers JS, Camacho TA, Eudicone JM, Forbes RA, Berman RM, Baker RA.
    Am J Manag Care; 2011 Dec; 17(12):793-801. PubMed ID: 22216750
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
    Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M.
    Psychother Psychosom; 2012 Dec; 81(2):87-97. PubMed ID: 22286203
    [Abstract] [Full Text] [Related]

  • 14. Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
    Weisler RH, Khan A, Trivedi MH, Yang H, Eudicone JM, Pikalov A, Tran QV, Berman RM, Carlson BX.
    J Clin Psychiatry; 2011 Apr; 72(4):548-55. PubMed ID: 20816039
    [Abstract] [Full Text] [Related]

  • 15. Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study.
    Jon DI, Kim DH, Seo HJ, Kwon YJ, Kim MD, Yang JC, Suh HS, Min KJ, Pae CU, Bahk WM.
    Clin Neuropharmacol; 2013 Apr; 36(5):157-61. PubMed ID: 24045606
    [Abstract] [Full Text] [Related]

  • 16. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR, Guo H, Németh G, Harsányi J, Thase ME.
    Psychopharmacol Bull; 2018 Jun 20; 48(4):62-80. PubMed ID: 30618475
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.
    Thase ME, Youakim JM, Skuban A, Hobart M, Augustine C, Zhang P, McQuade RD, Carson WH, Nyilas M, Sanchez R, Eriksson H.
    J Clin Psychiatry; 2015 Sep 20; 76(9):1224-31. PubMed ID: 26301701
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
    Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M.
    J Clin Psychiatry; 2012 Mar 20; 73(3):353-7. PubMed ID: 21939613
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E, T'joen C, McQuade RD, Carson WH, Marcus RN, Sanchez R, Owen R, Nameche L.
    Am J Psychiatry; 2008 Oct 20; 165(10):1316-25. PubMed ID: 18381903
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
    Boulton DW, Balch AH, Royzman K, Patel CG, Berman RM, Mallikaarjun S, Reeves RA.
    J Psychopharmacol; 2010 Apr 20; 24(4):537-46. PubMed ID: 18832427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.